piracetam has been researched along with Dysphagia in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Levetiracetam monotherapy at a dosage of 40 mg/kg/day improved the clinical findings, and seizures were controlled at the end of the first month of treatment." | 1.38 | Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy. ( Akın, R; Arslan, M; Ince, S; Ünay, B; Vurucu, S; Yiş, U, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, M | 1 |
| Yiş, U | 1 |
| Vurucu, S | 1 |
| Ince, S | 1 |
| Ünay, B | 1 |
| Akın, R | 1 |
| Mikati, MA | 1 |
| El Banna, D | 1 |
| Sinno, D | 1 |
| Mroueh, S | 1 |
1 trial available for piracetam and Dysphagia
| Article | Year |
|---|---|
Response of infantile spasms to levetiracetam.
Topics: Anticonvulsants; Body Weight; Brain; Deglutition Disorders; Dose-Response Relationship, Drug; Drug A | 2008 |
1 other study available for piracetam and Dysphagia
| Article | Year |
|---|---|
Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy.
Topics: Anticonvulsants; Child, Preschool; Deglutition Disorders; Dysarthria; Electroencephalography; Epilep | 2012 |